104 results
8-K
EX-99.1
IDXX
Idexx Laboratories, Inc.
1 May 24
IDEXX Laboratories Announces First Quarter Results
6:30am
payment in Q1 2023. Operating expense growth was driven by higher R&D spend related to advancing the Company's innovation agenda, including new platform
8-K
EX-99.1
IDXX
Idexx Laboratories, Inc.
5 Feb 24
Results of Operations and Financial Condition
6:30am
reflects increased investments in commercial resources and R&D project spend.
2024 Growth and Financial Performance Outlook
The following table
8-K
EX-99.1
IDXX
Idexx Laboratories, Inc.
1 Nov 23
Results of Operations and Financial Condition
6:30am
resolution payment in Q1 2023 and lapping of discrete 2022 R&D investments
WESTBROOK, Maine--(BUSINESS WIRE)--November 1, 2023--IDEXX Laboratories, Inc … controls and lapping of prior year R&D and commercial investments.
2023 Growth and Financial Performance Outlook
The Company is updating its full year
8-K
EX-99.1
0bn9ci
1 Aug 23
Results of Operations and Financial Condition
6:30am
8-K
EX-99.1
u0nmysg0c ncd88h0rvc
2 May 23
Results of Operations and Financial Condition
6:34am
8-K
EX-99.1
adf7zyv
2 Aug 22
IDEXX Laboratories Announces Second Quarter Results
6:31am
8-K
EX-99.1
yxl5hdol98f 26w045c8
4 May 22
IDEXX Laboratories Announces First Quarter Results
6:31am
8-K
EX-99.1
1s6 p5nfsm6n772xtk4
2 Feb 21
IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
6:31am
8-K
EX-99.1
jahtnf
29 Oct 20
IDEXX Laboratories Announces Third Quarter Results
6:31am
8-K
EX-99.1
yqll20f9 wdishklb70
31 Jul 20
IDEXX Laboratories Announces Second Quarter Results
8:43am